General Updates

SHUKRA PHARMACEUTICALS LTD. Date: October 6,2026 The Manager, Surveillance Department, National Stock Exchange of India Limited, Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai - 400051 Symbol: SIilTKRAPIIAR Sub: Clarification on Spurt in Price Dear Sir / Madam, This has reference to your ernail dated October 6,2026, regarding the significant increase in the price ofour security across Exchanges in the recent past. We would like to assure the Exchange that Shukra Pharmaceuticals Ltd strictly adheres to the compliance requirements outlined under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. All material events and corporate actions are disclosed to the stock exchanges promptly as and when they arise. We explicitly clariff that there is currently no unannounced material information or pending price- sensitive announcement that could influence the trading volume or price behavior of the Company's shares. Therefore, the recent spurt in the share price is entirely due to market driven conditions and natural trading dynamics. The Company has no role or influence over this movement. We request to take this information on your records. Thanking you, Yours faithfully, For Shukra Pharmaceuticals Ltd Name: Shivkant Dhakad Company Secretary & Compliance Officer ACS no. A80894 CIN : L24231G11993PtC0f 9079 Regd' Office : 3rd Flooq "VEER HOUSE" Opp. WIM office, Judges Bunglow Road, Bodakdeq Ahmedabad - 3g0 054. FactoryAdd. :795, Rakanpur, Sola-Santej Road, Ta. Kalol, Dist. Gandhinagar -3BZTZl,Gujara! tndia, ph. :e2764-2863L7